Literature DB >> 6453606

Richner-Hanhart syndrome (tyrosinaemia-II) (report of four cases without ocular involvement).

A Rehák, M M Selim, G Yadav.   

Abstract

Four cases of tyrosinaemia with cutaneous manifestations, but without ocular involvement, are reported in a family with consanguineous parents. The tyrosine levels in the serum and in the urine were normal in both parents, while in the offsprings the tyrosine levels were elevated 7 1/2-13 times in the serum and 3-13 times in the urine. Although the serum tyrosine levels in our cases were higher than most of the cases reported in the literature the eyes of all our patients were normal. The skin manifestations were very impressive, and varying degrees of mental retardation were present in all patients. The patients put on a low-protein diet improved considerably and have been kept symptom-free for 1 1/2 years. The possible implication of the discrepancy between the high serum levels and lack of ocular changes is discussed. Our results suggest that the Richner-Hanhart syndrome may include more than one distinct biochemical entity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6453606     DOI: 10.1111/j.1365-2133.1981.tb15320.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

1.  TAT gene mutation analysis in three Palestinian kindreds with oculocutaneous tyrosinaemia type II; characterization of a silent exonic transversion that causes complete missplicing by exon 11 skipping.

Authors:  G Maydan; B S Andresen; P P Madsen; M Zeigler; A Raas-Rothschild; A Zlotogorski; A Gutman; S H Korman
Journal:  J Inherit Metab Dis       Date:  2006-08-17       Impact factor: 4.982

2.  Dietetic therapy of Richner-Hanhart syndrome.

Authors:  T I Farag
Journal:  J R Soc Med       Date:  1993-08       Impact factor: 5.344

3.  Hereditary tyrosinaemia type II in a consanguineous Ashkenazi Jewish family: intrafamilial variation in phenotype; absence of parental phenotype effects on the fetus.

Authors:  D Chitayat; A Balbul; V Hani; O A Mamer; C Clow; C R Scriver
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

4.  Aminoacidopathies: a review of 3 years experience of investigations in a Kuwait hospital.

Authors:  G C Yadav; P C Reavey
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

Review 5.  Autosomal recessive disorders among Arabs: an overview from Kuwait.

Authors:  A S Teebi
Journal:  J Med Genet       Date:  1994-03       Impact factor: 6.318

6.  Richner-Hanhart syndrome (oculocutaneous tyrosinaemia, tyrosinaemia type II)

Authors:  D G Paige; P Clayton; A Bowron; J I Harper
Journal:  J R Soc Med       Date:  1992-12       Impact factor: 18.000

7.  Plantar keratoderma: a manifestation of tyrosinemia type II (Richner-Hanhart syndrome).

Authors:  Jihad T Al-Ratrout; Mohammed Al-Muzian; Mona Al-Nazer; Naseem A Ansari
Journal:  Ann Saudi Med       Date:  2005 Sep-Oct       Impact factor: 1.526

Review 8.  Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations.

Authors:  Jeffrey M Chinsky; Rani Singh; Can Ficicioglu; Clara D M van Karnebeek; Markus Grompe; Grant Mitchell; Susan E Waisbren; Muge Gucsavas-Calikoglu; Melissa P Wasserstein; Katie Coakley; C Ronald Scott
Journal:  Genet Med       Date:  2017-08-03       Impact factor: 8.822

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.